Mithraprabhu, Sridurga <br/><br/>
Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.  [electronic resource] 

 -  British journal of haematology  Aug 2013 
 - 559-62 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.12388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor--drug effects<br/>Depsipeptides--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histones--metabolism<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Indoles--pharmacology<br/>Multiple Myeloma--enzymology<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Panobinostat<br/>Protein Processing, Post-Translational--drug effects<br/>Pyrimidines--pharmacology<br/>Tubulin--metabolism<br/>Tumor Cells, Cultured--drug effects